This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (102)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic

A Pilot Study

Helena Cortez-Pinto, MD; John Chatham, PhD; V. P. Chacko, PhD; Cheryl Arnold, RTR; Asif Rashid, MD; Anna Mae Diehl, MD

JAMA. 1999;282:1659-1664.

Context  The mechanisms that drive progression from fatty liver to steatohepatitis and cirrhosis are unknown. In animal models, obese mice with fatty livers are vulnerable to liver adenosine triphosphate (ATP) depletion and necrosis, suggesting that altered hepatic energy homeostasis may be involved.

Objective  To determine if patients with fatty liver disease exhibit impaired recovery from hepatic ATP depletion.

Design  Laboratory analysis of liver ATP stores monitored by nuclear magnetic resonance spectroscopy before and after transient hepatic ATP depletion was induced by fructose injection. The study was conducted between July 15 and August 30, 1998.

Setting  University hospital.

Patients  Eight consecutive adults with biopsy-proven nonalcoholic steatohepatitis and 7 healthy age- and sex-matched controls.

Main Outcome Measure  Level of ATP 1 hour after fructose infusion in patients vs controls.

Results  In patients, serum aminotransferase levels were increased (P = .02 vs controls); albumin and bilirubin values were normal and clinical evidence of portal hypertension was absent in both groups. However, 2 patients had moderate fibrosis and 1 had cirrhosis on liver biopsy. Mean serum glucose, cholesterol, and triglyceride levels were similar between groups but patients weighed significantly more than controls (P = .02). Liver ATP levels were similar in the 2 groups before fructose infusion and decreased similarly in both after fructose infusion (P = .01 vs initial ATP levels). However, controls replenished their hepatic ATP stores during the 1-hour follow-up period (P<.02 vs minimum ATP) but patients did not. Hence, patients' hepatic ATP levels were lower than those of controls at the end of the study (P = .04). Body mass index (BMI) correlated inversely with ATP recovery, even in controls (R = -0.768; P = .07). Although BMI was greater in patients than controls (P = .02) and correlated strongly with fatty liver and serum aminotransferase elevations, neither of the latter 2 parameters nor the histologic severity of fibrosis strongly predicted hepatic ATP recovery.

Conclusions  These data suggest that recovery from hepatic ATP depletion becomes progressively less efficient as body mass increases in healthy controls and is severely impaired in patients with obesity-related nonalcoholic steatohepatitis.

Author Affiliations: Departments of Medicine (Drs Cortez-Pinto and Diehl), Radiology (Drs Chatham and Chacko and Ms Arnold), and Pathology (Dr Rashid), Johns Hopkins University School of Medicine, Baltimore, Md.

RELATED ARTICLE

November 3, 1999
JAMA. 1999;282(17):1689-1690.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent
Tetri et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2008;295:G987-G995.
ABSTRACT | FULL TEXT  

Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury
Serviddio et al.
Gut 2008;57:957-965.
ABSTRACT | FULL TEXT  

Evaluation of the Severity of Chronic Hepatitis C with 3-T1H-MR Spectroscopy
Orlacchio et al.
Am. J. Roentgenol. 2008;190:1331-1339.
ABSTRACT | FULL TEXT  

Nonalcoholic Fatty Liver Disease
Lall et al.
Am. J. Roentgenol. 2008;190:993-1002.
ABSTRACT | FULL TEXT  

Mitochondrial Uncoupling Protein-2 Mediates Steatotic Liver Injury following Ischemia/Reperfusion
Evans et al.
J. Biol. Chem. 2008;283:8573-8579.
ABSTRACT | FULL TEXT  

A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet
Baumgardner et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2008;294:G27-G38.
ABSTRACT | FULL TEXT  

Nonalcoholic Fatty Liver Disease and Obesity
Saadeh
Nutr Clin Pract 2007;22:1-10.
ABSTRACT | FULL TEXT  

Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease
Perseghin et al.
Am. J. Physiol. Endocrinol. Metab. 2006;291:E697-E703.
ABSTRACT | FULL TEXT  

Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
Medina et al.
Diabetes Care 2004;27:2057-2066.
ABSTRACT | FULL TEXT  

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery
Beymer et al.
Arch Surg 2003;138:1240-1244.
ABSTRACT | FULL TEXT  

Nonalcoholic Fatty Liver Disease
Angulo
NEJM 2002;346:1221-1231.
FULL TEXT  

Nonalcoholic Steatosis and Steatohepatitis: V. Mitochondrial dysfunction in steatohepatitis
Pessayre et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2002;282:G193-G199.
ABSTRACT | FULL TEXT  

Fatty liver vulnerability to endotoxin-induced damage despite NF-{kappa}B induction and inhibited caspase 3 activation
Yang et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2001;281:G382-G392.
ABSTRACT | FULL TEXT  

Hyperinsulinemia Predicts Fatal Liver Cancer but Is Inversely Associated With Fatal Cancer at Some Other Sites: The Paris Prospective Study
Balkau et al.
Diabetes Care 2001;24:843-849.
ABSTRACT | FULL TEXT  

Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg and Diehl
NEJM 2000;343:1467-1476.
FULL TEXT